Kourounakis AP - Search Results

1

EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit.

Tavridou A, Kaklamanis L, Papalois A, Kourounakis AP, Rekka EA, Kourounakis PN, Charalambous A, Manolopoulos VG. Tavridou A, et al. Among authors: kourounakis pn, kourounakis ap. J Pharmacol Exp Ther. 2007 Dec;323(3):794-804. doi: 10.1124/jpet.107.126375. Epub 2007 Sep 5. J Pharmacol Exp Ther. 2007. PMID: 17804677

2

Suppression of adjuvant-induced disease (AID) by a novel analgesic-opioid agonist which also possesses antioxidant activity (neuroimmunomodulation).

Hadjipetrou-Kourounakis L, Rekka E, Kourounakis A. Hadjipetrou-Kourounakis L, et al. Ann N Y Acad Sci. 1992 Apr 15;650:19-24. doi: 10.1111/j.1749-6632.1992.tb49089.x. Ann N Y Acad Sci. 1992. PMID: 1605475

3

Investigation of the effect of chamazulene on lipid peroxidation and free radical processes.

Rekka EA, Kourounakis AP, Kourounakis PN. Rekka EA, et al. Among authors: kourounakis pn, kourounakis ap. Res Commun Mol Pathol Pharmacol. 1996 Jun;92(3):361-4. Res Commun Mol Pathol Pharmacol. 1996. PMID: 8827832

4

Effect of guaiazulene on some cytochrome P450 activities. Implication in the metabolic activation and hepatotoxicity of paracetamol.

Kourounakis AP, Rekka EA, Kourounakis PN. Kourounakis AP, et al. Among authors: kourounakis pn. Arch Pharm (Weinheim). 1997 Jan-Feb;330(1-2):7-11. doi: 10.1002/ardp.19973300103. Arch Pharm (Weinheim). 1997. PMID: 9112807

5

Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity in rats.

Kourounakis AP, Rekka EA, Kourounakis PN. Kourounakis AP, et al. Among authors: kourounakis pn. J Pharm Pharmacol. 1997 Sep;49(9):938-42. doi: 10.1111/j.2042-7158.1997.tb06140.x. J Pharm Pharmacol. 1997. PMID: 9306266

6

Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs.

Kourounakis PN, Tsiakitzis K, Kourounakis AP, Galanakis D. Kourounakis PN, et al. Among authors: kourounakis ap. Toxicology. 2000 Apr 3;144(1-3):205-10. doi: 10.1016/s0300-483x(99)00208-5. Toxicology. 2000. PMID: 10781889

7

Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.

Koufaki M, Calogeropoulou T, Detsi A, Roditis A, Kourounakis AP, Papazafiri P, Tsiakitzis K, Gaitanaki C, Beis I, Kourounakis PN. Koufaki M, et al. Among authors: kourounakis pn, kourounakis ap. J Med Chem. 2001 Nov 22;44(24):4300-3. doi: 10.1021/jm010962w. J Med Chem. 2001. PMID: 11708933

8

Antioxidant potential of natural and synthesised polyprenylated hydroquinones.

Tziveleka LA, Kourounakis AP, Kourounakis PN, Roussis V, Vagias C. Tziveleka LA, et al. Among authors: kourounakis pn, kourounakis ap. Bioorg Med Chem. 2002 Apr;10(4):935-9. doi: 10.1016/s0968-0896(01)00346-7. Bioorg Med Chem. 2002. PMID: 11836101

9

Synthesis of new azulene derivatives and study of their effect on lipid peroxidation and lipoxygenase activity.

Rekka E, Chrysselis M, Siskou I, Kourounakis A. Rekka E, et al. Chem Pharm Bull (Tokyo). 2002 Jul;50(7):904-7. doi: 10.1248/cpb.50.904. Chem Pharm Bull (Tokyo). 2002. PMID: 12130848 Free article.

10

Effect of a novel NSAID derivative with antioxidant moiety on oxidative damage caused by liver and cerebral ischaemia-reperfusion in rats.

Kourounakis AP, Tsiakitzis K, Paramithiotis D, Kotzampassi K, Kourounakis PN. Kourounakis AP, et al. Among authors: kourounakis pn. J Pharm Pharmacol. 2002 Aug;54(8):1091-6. doi: 10.1211/002235702320266244. J Pharm Pharmacol. 2002. PMID: 12195823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters